newsfilter
← Latest News
GlobeNewswire·

TFF Pharmaceuticals Reports First Quarter Financial Results and Provides Corporate Update

Growing Body of Clinical Data from Ongoing Phase 2 Trial Suggests that Tacrolimus Inhalation Powder (TFF TAC) Could Represent an Important New Innovation for Optimizing Immunosuppressive Therapy in Lung Transplant